Horan Capital Advisors LLC. Sells 395 Shares of CVS Health Co. (NYSE:CVS)

Horan Capital Advisors LLC. trimmed its holdings in CVS Health Co. (NYSE:CVS) by 1.0% in the 3rd quarter, Holdings Channel reports. The fund owned 38,307 shares of the pharmacy operator’s stock after selling 395 shares during the quarter. Horan Capital Advisors LLC.’s holdings in CVS Health were worth $2,409,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health in the 3rd quarter worth $25,000. Livelsberger Financial Advisory acquired a new stake in CVS Health during the third quarter worth about $31,000. Reston Wealth Management LLC bought a new position in CVS Health during the third quarter valued at about $32,000. First Community Trust NA raised its holdings in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after acquiring an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new position in shares of CVS Health in the third quarter valued at $33,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Wells Fargo & Company raised shares of CVS Health from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $60.00 to $66.00 in a research note on Monday. UBS Group raised their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. Deutsche Bank Aktiengesellschaft lowered their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Finally, Evercore ISI increased their price objective on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a report on Tuesday, October 8th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and a consensus target price of $72.78.

CVS Health Stock Performance

Shares of CVS Health stock opened at $56.08 on Tuesday. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a market capitalization of $70.57 billion, a price-to-earnings ratio of 14.23, a PEG ratio of 0.92 and a beta of 0.55. The firm has a fifty day moving average of $59.19 and a two-hundred day moving average of $58.60.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company’s quarterly revenue was up 6.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.21 earnings per share. As a group, equities research analysts predict that CVS Health Co. will post 5.48 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Shareholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.74%. The ex-dividend date was Monday, October 21st. CVS Health’s payout ratio is presently 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.